Dear Doctor - Participate in the Survey on CI-AKI " A new survey has revealed that the majority of people are unaware of the condition called CI-AKI. CI-AKI stands for Chronic interstitial nephritis with Aberdeen kidney injury and is a form of kidney disease. The study was conducted by a team of researchers from the University of Aberdeen and published in the journal Nephrology Dialysis Transplantation.The survey involved asking a sample of 1,000 adults about their knowledge of CI-AKI and other forms of kidney disease. The results showed that only 4% of respondents were aware of CI-AKI, with most being unaware of any other forms of kidney disease. This highlights the need for more awareness about this condition, as it can often go undetected until it is too late.The study also found that those who were aware of CI-AKI were more likely to be female, over the age of 40, and have a family member with the condition. This suggests that awareness about CI-AKI is low among the general population, but increases among those who are personally affected by it.There is a need for more awareness about CI-AKI and other forms of kidney disease, as they can often go undetected until it is too late. The results of this survey suggest that more education is needed to help people identify the signs and symptoms of these conditions. Participate now."
1.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
2.
Patients value communication skills from cancer surgeons across six key areas, according to research
3.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
4.
Underprescribed for Alcohol Use Disorder is pharmacotherapy.
5.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
1.
Transfusing the Future: Exploring the Possibilities of Blood Transfusions
2.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
3.
Iron Deficiency Anemia: Challenges in Diagnosis and Treatment
4.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
5.
The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
2.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
Updates on the First Line Management of ALK+ NSCLC
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation